During the past decade, First Department of Cardiology, University of Athens conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "First Department of Cardiology, University of Athens" are "Aortic Valve Stenosis" (2 trials), "Atherosclerosis" (2 trials), "Coronary Artery Disease" (2 trials), "Acute Decompensated Heart Failure" (1 trials) and "Anesthesia, Local" (1 trials). Many other conditions were trialed in "First Department of Cardiology, University of Athens" in a lesser frequency.

Most popular intervention types in "First Department of Cardiology, University of Athens" are "Drug" (3 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atorvastatin vs Placebo" (1 trials), "Atorvastatin, high vs low dose" (1 trials), "Diesel exhaust" (1 trials), "High-dose furosemide" (1 trials) and "Local anesthetic" (1 trials). Other intervention names were less common.

The vast majority of trials in "First Department of Cardiology, University of Athens" are 7 trials for "All" genders.

Currently, there are NaN active trials in "First Department of Cardiology, University of Athens". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in First Department of Cardiology, University of Athens, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in First Department of Cardiology, University of Athens, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".